Johnson & Johnson operates through two primary business segments: Innovative Medicine and MedTech. The Innovative Medicine division focuses on developing prescription drugs across therapeutic areas such as oncology, immunology, neuroscience, and infectious diseases, featuring key products like Darzalex, Stelara, and Tremfya. The MedTech segment provides medical devices and technologies for interventional solutions, orthopedics, surgery, and vision care. With a geographic footprint spanning the globe, the company serves healthcare professionals, hospitals, and patients worldwide. As one of the world's most valuable healthcare companies, Johnson & Johnson maintains a highly competitive position driven by substantial research and development investments and strategic acquisitions.
